Mutated KRAS Results in Overexpression of DUSP4, a MAP-kinase Phosphatase, and SMYD3, a Histone Methyltransferase, in Rectal Carcinomas

Genes Chromosomes and Cancer - United States
doi 10.1002/gcc.20811
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Role of the SMYD3 Histone Methyltransferase in Tumorigenesis

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

Smyd3, a Histone Methyltransferase, Modulates the Growth and Differentiation of Human Cardiac Stem Cells

BMC Genomics
BiotechnologyGenetics
2014English

RAD21 Cohesin Overexpression Is a Prognostic and Predictive Marker Exacerbating Poor Prognosis in KRAS Mutant Colorectal Carcinomas

British Journal of Cancer
Cancer ResearchOncology
2014English

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Frontiers in Oncology
Cancer ResearchOncology
2020English

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Science
MultidisciplinaryPhilosophy of ScienceHistory
2008English

DUSP4 Phosphatase Puts the Brakes on DLBCL

Journal of Experimental Medicine
MedicineAllergyImmunology
2015English

Novel Protective Role for MAP Kinase Phosphatase 2 in Inflammatory Arthritis

RMD Open
RheumatologyAllergyImmunology
2019English

Histone Methyltransferase and Histone Methylation in Inflammatory T-Cell Responses

Immunotherapy
OncologyAllergyImmunology
2013English

Mitogen-Activated Protein (MAP) Kinase Is Regulated by the MAP Kinase Phosphatase (MKP-1) in Vascular Smooth Muscle Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy